Clinical Trial

Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery

Study acronym: Periop HFNO
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to assess whether perioperative use of high-flow nasal oxygen (HFNO) during the period from induction of anesthesia until discharge from the post-anesthesia care unit in patients undergoing robotic-assisted surgery reduces perioperative oxygen desaturation and postoperative pulmonary complications.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-03
Trial Details
NCT Number NCT07591610
Lead Sponsor Beth Israel Deaconess Medical Center
Collaborators: Fisher and Paykel Healthcare
Conditions Robotic Surgery
Enrollment 190 participants
Start Date 2026-08-01
Primary Completion 2029-07-30 (estimated)
Study Completion 2029-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-02